deltatrials
Completed PHASE2 NCT00132405

Study of ALGRX 3268 for Needlestick Pain in Children

Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effectiveness and Safety of ALGRX 3268 0.5 Mg/20 Bar at the Back of the Hand in Pediatric Subjects

Sponsor: AlgoRx Pharmaceuticals

Conditions Pain
Interventions ALGRX 3268
Updated 5 times since 2017 Last updated: Oct 7, 2005 Started: May 31, 2004 Completion: Sep 30, 2004

This PHASE2 trial investigates Pain and is currently completed. AlgoRx Pharmaceuticals leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

May 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AlgoRx Pharmaceuticals
Data source: AlgoRx Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Hartford, United States